Similar articles

• Letter by Marín et al regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study".

  Marín F, Fauchier L, Rubboli A. Marín F, et al. Circulation. 2013 Apr 30;127(17):e584. doi: 10.1161/CIRCULATIONAHA.112.141838. Circulation. 2013. PMID: 23630091 No abstract available.
• Response to letter regarding article, "Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study".

  Lamberts M, Olesen JB, Ruwald MH, Hansen CM, Karasoy D, Kristensen SL, Køber L, Torp-Pedersen C, Gislason GH, Hansen ML. Lamberts M, et al. Circulation. 2013 Apr 30;127(17):e585. doi: 10.1161/circulationaha.113.001654. Circulation. 2013. PMID: 23762910 No abstract available.
• Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.

  Lopes RD, Li L, Granger CB, Wang TY, Foody JM, Funk M, Peterson ED, Alexander KP. Lopes RD, et al. Am J Med. 2012 Sep;125(9):897-905. doi: 10.1016/j.amjmed.2012.04.006. Epub 2012 Jul 13. Am J Med. 2012. PMID: 22795814
• Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.

  Cairns JA, McMurtry MS. Cairns JA, et al. Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006. Can J Cardiol. 2013. PMID: 23790600 Review.
• Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?

  Duerschmied D, Brachmann J, Darius H, Frey N, Katus HA, Rottbauer W, Schäfer A, Thiele H, Bode C, Zeymer U. Duerschmied D, et al. Clin Res Cardiol. 2018 Jul;107(7):533-538. doi: 10.1007/s00392-018-1242-2. Epub 2018 Apr 20. Clin Res Cardiol. 2018. PMID: 29679144 Review.